erlotinib hydrochloride has been researched along with Chylopericardium in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cecconi, M; Lane, K; Thomas, C | 1 |
| Buhl, R; Fischer, B; Makowski, J; Meier, S; Post, F; Schad, A; Schadmand-Fischer, S; Sebastian, M; Springer, E; Taube, C; Wiewrodt, R | 1 |
2 other study(ies) available for erlotinib hydrochloride and Chylopericardium
| Article | Year |
|---|---|
Pulmonary embolism with haemorrhagic pericardial effusion and tamponade: a clinical dilemma.
Topics: Anticoagulants; Carcinoma, Non-Small-Cell Lung; Cardiac Tamponade; Diagnosis, Differential; Drainage; Erlotinib Hydrochloride; Female; Humans; Lung Neoplasms; Middle Aged; Multiple Organ Failure; Pericardial Effusion; Protein Kinase Inhibitors; Pulmonary Embolism; Quinazolines; Treatment Outcome; Vena Cava Filters | 2014 |
[Hemorrhagic pericardial effusion and multiple pulmonary nodules in a 37 year old male who has "never smoked"].
Topics: Adult; Erlotinib Hydrochloride; Hemorrhage; Humans; Lung Neoplasms; Male; Multiple Pulmonary Nodules; Pericardial Effusion; Protein Kinase Inhibitors; Quinazolines; Smoking; Treatment Outcome | 2009 |